NeuroMetrix, Inc.
NURO · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,143 | $8,032 | $7,285 | $7,359 |
| - Cash | $1,428 | $922 | $1,607 | $1,260 |
| + Debt | $107 | $143 | $177 | $209 |
| Enterprise Value | $6,822 | $7,254 | $5,855 | $6,308 |
| Revenue | $583 | $587 | $769 | $1,094 |
| % Growth | -0.8% | -23.6% | -29.7% | – |
| Gross Profit | $359 | $312 | $492 | $517 |
| % Margin | 61.6% | 53.1% | 64% | 47.3% |
| EBITDA | -$1,724 | -$1,682 | -$1,737 | -$3,229 |
| % Margin | -295.8% | -286.4% | -225.8% | -295.3% |
| Net Income | -$1,780 | -$1,508 | -$1,488 | -$3,030 |
| % Margin | -305.5% | -256.8% | -193.5% | -277% |
| EPS Diluted | -0.87 | -0.75 | -0.74 | -1.67 |
| % Growth | -16% | -1.4% | 55.7% | – |
| Operating Cash Flow | -$1,890 | -$1,792 | -$1,364 | -$2,081 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$1,890 | -$1,792 | -$1,364 | -$2,081 |